Literature DB >> 16574109

Upregulation of hypoxia-induced mitogenic factor in bacterial lipopolysaccharide-induced acute lung injury.

Qiangsong Tong1, Liduan Zheng, Qiaohua Kang, Jeffrey Dodd-O, John Langer, Bo Li, Danming Wang, Dechun Li.   

Abstract

Hypoxia-induced mitogenic factor (HIMF), also known as FIZZ1 (found in inflammatory zone), plays important roles in lung inflammation. We found that intraperitoneal injection of lipopolysaccharide (LPS) induced intensive HIMF production exclusively in mouse lung, but not in the heart, liver, spleen or kidney. This HIMF production, at least partly, contributes to LPS-induced vascular cell adhesion molecule-1 (VCAM-1) upregulation and mononuclear cell sequestration to lung parenchyma, while protecting alveolar type II cells from LPS-resulted decrease in surfactant protein-C production and cell death. These data indicate that HIMF participates in LPS-induced acute lung injury and inflammation through modulating VCAM-1 and SP-C expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574109     DOI: 10.1016/j.febslet.2006.03.027

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Apolipoprotein M Protects Against Lipopolysaccharide-Induced Acute Lung Injury via Sphingosine-1-Phosphate Signaling.

Authors:  Bin Zhu; Guang-Hua Luo; Yue-Hua Feng; Miao-Mei Yu; Jun Zhang; Jiang Wei; Chun Yang; Ning Xu; Xiao-Ying Zhang
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

2.  Resistin-like molecule α promotes pathogenic Th17 cell responses and bacterial-induced intestinal inflammation.

Authors:  Lisa C Osborne; Karen L Joyce; Theresa Alenghat; Gregory F Sonnenberg; Paul R Giacomin; Yurong Du; Kirk S Bergstrom; Bruce A Vallance; Meera G Nair
Journal:  J Immunol       Date:  2013-01-25       Impact factor: 5.422

3.  Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMalpha) induces the vascular and hemodynamic changes of pulmonary hypertension.

Authors:  Daniel J Angelini; Qingning Su; Kazuyo Yamaji-Kegan; Chunling Fan; John T Skinner; Hunter C Champion; Michael T Crow; Roger A Johns
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-01-09       Impact factor: 5.464

4.  Resistin-like molecule-beta in scleroderma-associated pulmonary hypertension.

Authors:  Daniel J Angelini; Qingning Su; Kazuyo Yamaji-Kegan; Chunling Fan; Xingwu Teng; Paul M Hassoun; Stephen C Yang; Hunter C Champion; Rubin M Tuder; Roger A Johns
Journal:  Am J Respir Cell Mol Biol       Date:  2009-02-27       Impact factor: 6.914

5.  Toll-like receptor 4 monoclonal antibody attenuates lipopolysaccharide-induced acute lung injury in mice.

Authors:  Zhijie He; Xiaotong Chen; Shouping Wang; Zijun Zou
Journal:  Exp Ther Med       Date:  2014-06-24       Impact factor: 2.447

6.  Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung.

Authors:  Meera G Nair; Yurong Du; Jacqueline G Perrigoue; Colby Zaph; Justin J Taylor; Michael Goldschmidt; Gary P Swain; George D Yancopoulos; David M Valenzuela; Andrew Murphy; Margaret Karow; Sean Stevens; Edward J Pearce; David Artis
Journal:  J Exp Med       Date:  2009-04-06       Impact factor: 14.307

7.  Flavonoids of Polygonum hydropiper L. attenuates lipopolysaccharide-induced inflammatory injury via suppressing phosphorylation in MAPKs pathways.

Authors:  Junyu Tao; Yingyi Wei; Tingjun Hu
Journal:  BMC Complement Altern Med       Date:  2016-01-22       Impact factor: 3.659

Review 8.  The Role of Hypoxia-Induced Mitogenic Factor in Organ-Specific Inflammation in the Lung and Liver: Key Concepts and Gaps in Knowledge Regarding Molecular Mechanisms of Acute or Immune-Mediated Liver Injury.

Authors:  Sananda Pai; Dolores B Njoku
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

Review 9.  Hypoxia-Induced Mitogenic Factor: A Multifunctional Protein Involved in Health and Disease.

Authors:  Moyang Lv; Wenjuan Liu
Journal:  Front Cell Dev Biol       Date:  2021-07-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.